Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)

Market Cap	3.34B -52.3%
Revenue (ttm)	21.33B -21.8%
Net Income	-959.38M
EPS	-0.36
Shares Out	2.63B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,069,182
Open	1.260
Previous Close	1.280
Day's Range	1.260 - 1.310
52-Week Range	1.190 - 5.700
Beta	0.10
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About SHE:000078

Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, manufacturing, and distribution of pharmaceuticals in China. The company also provides distribution of medical devices, and other medical supplies, as well as related value-added services. It serves medical institutions, drug retailers, and distributors. Shenzhen Neptunus Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 6,734
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000078

Financial Performance

In 2025, SHE:000078's revenue was 26.67 billion, a decrease of -12.04% compared to the previous year's 30.32 billion. Losses were -563.06 million, -52.82% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error